Top Story

Herantis Pharma pursues phase 2 study for dry eye treatment

September 15, 2014

The U.S. Food and Drug Administration has cleared the Investigational New Drug application of Herantis Pharma for a phase 2 clinical study of Cis-UCA eye drops for dry eye syndrome.

According to a press release from Herantis, patient enrollment is planned to begin by the end of this year.

Breaking News

Jetrea approved in South Korea for symptomatic vitreomacular adhesion

September 8, 2014
Jetrea has been approved in South Korea for the treatment of symptomatic vitreomacular adhesion, according to a ThromboGenics press release.This is the fourth country in…
Breaking News

Ozurdex approved in EU for treatment of DME

September 2, 2014
The European Commission has extended marketing authorization for Ozurdex for the treatment of diabetic macular edema in certain patients, according to an Allergan press…

California optometry scope expansion bill tabled until 2015

August 27, 2014
A bill in California that intended to allow optometrists to use therapeutic lasers and pharmaceutical agents approved by the U.S. Food and Drug Administration as well as…
figure

A Fluoroquinolone with Broad Spectrum Antibiotic Potency

This activity is sponsored by Bausch + Lomb.

Watch as leading optometrists discuss the signs and symptoms of bacterial conjunctivitis and weigh various treatment…
More »
figure

Blepharitis Management: Current Thinking and Clinical Insights

This activity is sponsored by Bausch + Lomb.

Blepharitis Management: Current Thinking and Clinical Insights
More »

Filter By:

FDA News

Herantis Pharma pursues phase 2 study for dry eye treatment

September 15, 2014
The U.S. Food and Drug Administration has cleared the Investigational New Drug application of Herantis Pharma for a phase 2 clinical study of Cis-UCA…
Breaking News

Jetrea approved in South Korea for symptomatic vitreomacular adhesion

September 8, 2014
Jetrea has been approved in South Korea for the treatment of symptomatic vitreomacular adhesion, according to a ThromboGenics press release.This is…
Breaking News

Ozurdex approved in EU for treatment of DME

September 2, 2014
The European Commission has extended marketing authorization for Ozurdex for the treatment of diabetic macular edema in certain patients, according…

California optometry scope expansion bill tabled until 2015

August 27, 2014
A bill in California that intended to allow optometrists to use therapeutic lasers and pharmaceutical agents approved by the U.S. Food and Drug…
FDA News

FDA grants labeling extension to class 3 contact lenses, IOLS

August 26, 2014
The U.S. Food and Drug Administration announced on its website that the Center for Devices and Radiological Health has granted a 1-year extension of…

'Be neither fish nor fowl'

August 13, 2014
This wise saying has roots that go back at least to the 15th century. It has been applied in many different contexts but applies today as good advice…

Top 6 stories from organized optometry

August 8, 2014
The optometric industry’s associations have been busy the past 2 weeks, as evidenced by Healio’s recent headlines. The groups have named…
FDA News

FDA, ophthalmic organizations to sponsor microbiology workshop

August 8, 2014
The Food and Drug Administration Center for Devices and Radiological Health, the American Academy of Optometry, the American Optometric Association…

Alcon says new contact lens pricing strategy will help sellers, patients

August 7, 2014
Alcon Laboratories Inc. submitted a written statement to the Senate Subcommittee on Antitrust Competition Policy and Consumer Rights regarding its…

ACOE authorizes Virginia optometry school to move toward accreditation

August 6, 2014
The Accreditation Council on Optometric Education has designated Emory & Henry College as a "stage one applicant," according to a press release…
More Headlines »